Repeatability of health economic data in COPD

被引:5
作者
Nielsen, Rune [1 ]
Johannessen, Ane [2 ]
Schnelle, Hege Marie [1 ]
Bakke, Per S. [1 ,3 ]
Askildsen, Jan E. [4 ,5 ]
Omenaas, Ernst R. [1 ,2 ]
Gulsvik, Amund [1 ,3 ]
机构
[1] Univ Bergen, Haukeland Univ Hosp, Inst Med, N-5021 Bergen, Norway
[2] Haukeland Hosp, Clin Res Ctr, N-5021 Bergen, Norway
[3] Haukeland Hosp, Dept Thorac Med, N-5021 Bergen, Norway
[4] Univ Bergen, Dept Econ, N-5007 Bergen, Norway
[5] Univ Bergen, Rokkan Ctr, N-5015 Bergen, Norway
关键词
Healthcare costs; Chronic obstructive pulmonary disease; Reproducibility of results; Repeatability; Reliability;
D O I
10.1016/j.rmed.2008.06.008
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Background: Little is known concerning the precision of self-reported health economic data. Aim: To investigate the repeatability of self-reported health economic cost and utilization data in subjects with chronic obstructive pulmonary disease (COPD). Methods: Twelve weeks after inclusion, a physician and a nurse in random order interviewed 29 subjects with post-bronchodilator COPD included from a research registry of COPD patients. The interview recorded healthcare utilization and costs, sick leave, exacerbations and quality of life (QoL). Variation of individual agreement of observations was described estimating kappa statistics and 95% limits of agreement. Results: Mean age was 63 years (standard deviation (SD) 10) and 17 participants were men. Average FEV(1)% predicted was 56% (SD 15). For sick leave, exacerbation, healthcare provider visit, change of medication, assistance and leisure time the kappa values were 1.00, 0.73, 0.73, 0.66, 0.63 and 0.54, respectively. The physician recorded fewer days of exacerbation and fewer contacts with healthcare providers than the nurse (p = 0.01 and p = 0.05, respectively). The 95% limits of agreement for costs of drugs were -690 to +710 Norwegian Kroner (NOK), -1200 to +899 NOK for costs of healthcare providers and -20 to +26 for QoL as measured by a visual analogue scale. Conclusion: Repeatability of economic data from COPD patients showed considerable variation. This issue should be addressed when analyzing cost data from interviews and when designing studies on health economy. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1556 / 1562
页数:7
相关论文
共 22 条
[1]
Reproducibility of indoor environment characteristics obtained in a walk through questionnaire. A pilot study [J].
Aamodt, AH ;
Bakke, P ;
Gulsvik, A .
INDOOR AIR-INTERNATIONAL JOURNAL OF INDOOR AIR QUALITY AND CLIMATE, 1999, 9 (01) :26-32
[2]
ALTMAN DG, 1991, COMP GROUPS CATEGORI, P229
[3]
ANTIBIOTIC-THERAPY IN EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY-DISEASE [J].
ANTHONISEN, NR ;
MANFREDA, J ;
WARREN, CPW ;
HERSHFIELD, ES ;
HARDING, GKM ;
NELSON, NA .
ANNALS OF INTERNAL MEDICINE, 1987, 106 (02) :196-204
[4]
The cost of treating patients with COPD in Denmark - A population study of COPD patients compared with non-COPD controls [J].
Bilde, Lone ;
Rud Svenning, Anders ;
Dollerup, Jens ;
Baekke Borgeskov, Hanne ;
Lange, Peter .
RESPIRATORY MEDICINE, 2007, 101 (03) :539-546
[5]
STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT [J].
BLAND, JM ;
ALTMAN, DG .
LANCET, 1986, 1 (8476) :307-310
[6]
Brogger JC, 2000, INT J TUBERC LUNG D, V4, P83
[7]
EuroQol: The current state of play [J].
Brooks, R .
HEALTH POLICY, 1996, 37 (01) :53-72
[8]
International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study [J].
Buist, A. Sonia ;
McBurnie, Mary Ann ;
Vollmer, William M. ;
Gillespie, Suzanne ;
Burney, Peter ;
Mannino, David M. ;
Menezes, Ana M. B. ;
Sullivan, Sean D. ;
Lee, Todd A. ;
Weiss, Kevin B. ;
Jensen, Robert L. ;
Marks, Guy B. ;
Gulsvik, Amund ;
Nizankowska-Mogilnicka, Ewa .
LANCET, 2007, 370 (9589) :741-750
[9]
Patient self-reports in pharmacoeconomic studies - Their use and impact on study validity [J].
Evans, C ;
Crawford, B .
PHARMACOECONOMICS, 1999, 15 (03) :241-256
[10]
The meaning of kappa: Probabilistic concepts of reliability and validity revisited [J].
GuggenmoosHolzmann, I .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1996, 49 (07) :775-782